Sanjiv Patel, President and CEO of Relay Therapeutics ($RLAY), made six open market sales of company shares over the past year, totaling about $1.17 million. His most recent sale occurred on January 6, 2026. These transactions rank 4,556th among 11,678 individual insiders by sale value, below the average of $8.6 million per insider and 6.4 sales. Patel had no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 13, 2026 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Stock Option (Right to Buy) | 1450000 | $0.00 | 1,450,000.0000 | 173,322,385 | 9999.99% | 0.84% |
| Jan. 6, 2026 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 43168 | $7.82 | 1,547,944.0000 | 173,322,385 | 2.71% | 0.02% |
| Dec. 31, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Common Stock | 994 | $2.99 | 1,591,112.0000 | 173,322,385 | 0.06% | 0.00% |
| Nov. 3, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 62073 | $7.00 | 1,590,118.0000 | 173,322,385 | 3.76% | 0.04% |
| July 9, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 42740 | $3.57 | 1,670,830.0000 | 169,521,849 | 2.49% | 0.03% |
| July 9, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 18639 | $3.57 | 1,652,191.0000 | 169,521,849 | 1.12% | 0.01% |
| June 30, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Common Stock | 5000 | $2.94 | 1,713,570.0000 | 169,521,849 | 0.29% | 0.00% |
| April 23, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 18653 | $2.97 | 1,708,570.0000 | 169,521,849 | 1.08% | 0.01% |
| April 23, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 42769 | $2.97 | 1,727,223.0000 | 169,521,849 | 2.42% | 0.03% |
| Feb. 11, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Common Stock | 332465 | $0.00 | 1,845,316.0000 | 0 | 21.98% | 0.00% |
| Feb. 13, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 75324 | $3.70 | 1,769,992.0000 | 0 | 4.08% | 0.00% |
| Feb. 11, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 140182 | $3.85 | 1,512,851.0000 | 0 | 8.48% | 0.00% |
| Jan. 22, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 125000 | $4.80 | 1,778,033.0000 | 0 | 6.57% | 0.00% |
| Jan. 23, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 125000 | $4.78 | 1,653,033.0000 | 0 | 7.03% | 0.00% |
| Jan. 21, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 125000 | $4.52 | 1,903,033.0000 | 0 | 6.16% | 0.00% |
| Jan. 10, 2025 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Stock Option (Right to Buy) | 1105000 | $0.00 | 1,105,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 16, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 100000 | $5.00 | 2,028,033.0000 | 0 | 4.70% | 0.00% |
| July 25, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 50000 | $0.00 | 518,779.0000 | 0 | 8.79% | 0.00% |
| July 26, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 36706 | $0.00 | 482,073.0000 | 0 | 7.08% | 0.00% |
| July 25, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 50000 | $5.04 | 2,178,033.0000 | 0 | 2.35% | 0.00% |
| July 26, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 36706 | $5.04 | 2,164,739.0000 | 0 | 1.72% | 0.00% |
| July 26, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 36706 | $9.07 | 2,128,033.0000 | 0 | 1.70% | 0.00% |
| July 25, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 50000 | $9.16 | 2,128,033.0000 | 0 | 2.30% | 0.00% |
| June 30, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Common Stock | 2108 | $5.54 | 2,128,033.0000 | 0 | 0.10% | 0.00% |
| Jan. 16, 2024 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Common Stock | 762360 | $0.00 | 2,125,925.0000 | 0 | 55.91% | 0.00% |
| June 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Common Stock | 1662 | $10.68 | 1,363,565.0000 | 0 | 0.12% | 0.00% |
| Feb. 8, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 14000 | $0.00 | 582,779.0000 | 0 | 2.35% | 0.00% |
| Feb. 7, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 14000 | $5.04 | 1,375,903.0000 | 0 | 1.03% | 0.00% |
| Feb. 7, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 14000 | $21.45 | 1,361,903.0000 | 0 | 1.02% | 0.00% |
| Feb. 8, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 14000 | $5.04 | 1,375,903.0000 | 0 | 1.03% | 0.00% |
| Feb. 8, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 14000 | $20.98 | 1,361,903.0000 | 0 | 1.02% | 0.00% |
| Feb. 9, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 14000 | $5.04 | 1,375,903.0000 | 0 | 1.03% | 0.00% |
| Feb. 9, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 14000 | $20.55 | 1,361,903.0000 | 0 | 1.02% | 0.00% |
| Feb. 7, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 14000 | $0.00 | 596,779.0000 | 0 | 2.29% | 0.00% |
| Feb. 9, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 14000 | $0.00 | 568,779.0000 | 0 | 2.40% | 0.00% |
| Oct. 28, 2022 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | G | Common Stock | 254554 | $0.00 | 1,361,903.0000 | 0 | 22.99% | 0.00% |
| Oct. 28, 2022 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | G | Common Stock | 254554 | $0.00 | 1,361,903.0000 | 0 | 15.75% | 0.00% |
| Jan. 18, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 28000 | $20.87 | 1,361,903.0000 | 0 | 2.01% | 0.00% |
| Jan. 19, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 28000 | $5.04 | 1,389,903.0000 | 0 | 2.06% | 0.00% |
| Jan. 19, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 28000 | $20.02 | 1,361,903.0000 | 0 | 2.01% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 666,779.0000 | 0 | 4.03% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | S | Common Stock | 28000 | $20.23 | 1,361,903.0000 | 0 | 2.01% | 0.00% |
| Jan. 19, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 610,779.0000 | 0 | 4.38% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Stock Option (Right to Buy) | 701680 | $0.00 | 701,680.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | A | Stock Option (Right to Buy) | 701680 | $0.00 | 701,680.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 28000 | $5.04 | 1,389,903.0000 | 0 | 2.06% | 0.00% |
| Jan. 18, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Stock Option (Right to Buy) | 28000 | $0.00 | 638,779.0000 | 0 | 4.20% | 0.00% |
| Jan. 18, 2023 | Relay Therapeutics, Inc. | $RLAY | Patel Sanjiv | President and CEO | M | Common Stock | 28000 | $5.04 | 1,389,903.0000 | 0 | 2.06% | 0.00% |